Table 2.

Epidemiology of Our Patients Diagnosed with Moderate-to-Severe Psoriasis and Treated with Dimethyl Fumarate

Baseline Characteristics	N=30
Woman, n (%)	17 (56.7)
Man, n (%)	13 (43.3)
Age, mean (SD), years	50 (15.8)
BMI, mean (SD), kg/m2	27 (5.7)
BMI <25, n (%)	10 (33.3)
BMI 25–30, n (%) overweight	15 (50.0)
BMI >30, n (%) obesity	5 (17.7)
PASI before treatment, median (min-max)	10 (3.6–20)
BSA before treatment, median (min-max)	17 (3–59)
Comorbidities, n (%)	17 (56.7)

Abbreviations: BMI, body mass index; BSA, body surface area; n, number; PASI, Psoriasis Area and Severity Index; SD, standard deviation.